Impact of age extension to include 47–49 year old women on the workload of the surgical department of a single Breast Cancer Screening Unit – The first non-randomized experience in UK

Abstract

This study highlights the impact of the 47-49 year age extension within the breast screening programme on the workload of the surgical department of a UK Breast Cancer Screening Unit offering non-randomized invitations. The study will inform other surgical units of expected workload when age extension is fully implemented.

Cost of extending the NHS breast screening age range in England

“…We cannot yet know the full effects—good and bad—of extending the age range for breast cancer screening, but a study from Devon, southwest England, sheds light on one aspect: the numbers of extra surgical procedures in the younger women screened 23. In Devon, all women aged 47-49 are invited for screening because Inhealth, the region’s breast cancer screening provider, is not permitted to take part in clinical trials.…”